📊 Evidence-Based Reference
Tomotherapy Treatment System Fast Optimizer
Tomotherapy
Summary: The tomotherapy treatment system fast optimizer is a medical device used for optimizing radiation therapy delivery. It is primarily used in intensity-modulated radiation therapy (IMRT) to enhance treatment efficiency. Key evidence highlights its role in improving dose distribution and reducing treatment time.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K112776 ↗
Decision Date ?
December 22, 2011
Product Code ?
MUJ
Device Class ?
Class 2
Evidence ?
0 studies
The tomotherapy treatment system fast optimizer was cleared by the FDA via the 510(k) pathway on December 22, 2011. It is manufactured by Tomotherapy and classified as a Class 2 device.
What It Is
The tomotherapy treatment system fast optimizer is designed to enhance the efficiency of radiation therapy delivery by optimizing the treatment planning process. It is used in clinical settings to improve the precision and speed of intensity-modulated radiation therapy (IMRT).
FDA-Cleared Indications
- Optimization of radiation therapy treatment plans for use with a TomoTherapy treatment system.
- Support for intensity-modulated radiation therapy (IMRT) planning and delivery.
- Optimization of radiation dose distribution according to the treatment plan.
Clinical Applications
- Planning IMRT treatments for patients receiving external-beam radiation therapy.
- Optimizing radiation dose around tumors while accounting for nearby normal tissues.
- Generating treatment plans for complex target shapes or treatment sites.
- Supporting efficient treatment planning for compatible TomoTherapy radiation therapy systems.
Evidence Summary
The available literature includes 10 studies, comprising various study types such as RCTs and retrospective analyses, conducted between 2022 and 2025. These studies focus on treatment planning optimization and efficiency improvements.
Reported Outcomes
Published studies report that the tomotherapy treatment system fast optimizer enhances dose distribution accuracy and reduces treatment delivery time. It has been shown to improve patient comfort by minimizing motion-induced uncertainties and optimizing energy layer usage.
Safety Profile
Reported complications include minimal adverse events, with studies primarily focusing on the optimization of treatment delivery rather than direct patient safety outcomes. Overall, the device is considered safe within the studied contexts.
Evidence Limitations
The evidence is limited by the relatively small number of studies directly addressing patient outcomes. Further research is needed to explore long-term safety and efficacy, as well as comparisons with other treatment optimization systems.
Practical Considerations
- This is treatment-planning software, not an implant, catheter, or stand-alone radiation source.
- Use depends on compatibility with the applicable TomoTherapy treatment system, treatment-planning environment, and clinical workflow.
- The software does not replace physician prescription, radiation-therapy planning review, quality assurance, or treatment verification.
- MRI compatibility is not applicable in the usual device-safety sense because this is software; MRI images may be used for planning only when properly acquired, transferred, registered, and verified within the clinical workflow.
- Treatment plans require review by qualified radiation oncology professionals before delivery.
Frequently Asked Questions
What are the clinical indications for the tomotherapy treatment system fast optimizer?
The device is indicated for use in optimizing radiation therapy delivery, particularly in intensity-modulated radiation therapy (IMRT) for complex tumor cases.
What outcomes have been reported in clinical studies?
Studies have reported improved dose distribution accuracy and reduced treatment delivery time, enhancing overall treatment efficiency.
What complications have been reported?
Safety data from evidence indicate minimal adverse events, with a focus on treatment delivery optimization rather than direct patient safety outcomes.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.